APA (7th ed.) Citation

Houmsse, M., Muskara, A., Pasca, D., Roy, A., Sughra, S., Ghazi, S., . . . Husain, M. (2025). Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review. Cancers, 17(5), 827. https://doi.org/10.3390/cancers17050827

Chicago Style (17th ed.) Citation

Houmsse, Mustafa, Andrew Muskara, Damaris Pasca, Arnab Roy, Sana Sughra, Sanam Ghazi, Daniel Addison, and Marium Husain. "Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review." Cancers 17, no. 5 (2025): 827. https://doi.org/10.3390/cancers17050827.

MLA (9th ed.) Citation

Houmsse, Mustafa, et al. "Characterizing Cardiotoxicity of FDA-Approved Soft Tissue Sarcoma Targeted Therapies and Immune Checkpoint Inhibitors: A Systematic Review." Cancers, vol. 17, no. 5, 2025, p. 827, https://doi.org/10.3390/cancers17050827.